Dexcom Inc (NASDAQ:DXCM)
| 383.54 Delayed Data As of 4:00pm ET |  -11.62 / -2.94%Today’s Change | 318.45 Today|||52-Week Range 659.45 | -28.57% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $40.9B |
Company Description
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
Contact Information
DexCom, Inc. 6340 Sequence Drive San Diego California 92121 |
Employees
Shareholders
| Mutual fund holders | 96.22% |
| Individual stakeholders | 10.14% |
| Other institutional | 1.78% |
Top Executives
| Kevin Ronald Sayer | Chairman, President & Chief Executive Officer |
| Jereme M Sylvain | SVP-Finance, Chief Financial & Accounting Officer |
| Andrew K. Balo | EVP-Clinical Affairs, Regulatory Strategy |
| Jacob S. Leach | Chief Technology Officer & Executive VP |
| Shelly R. Selvaraj | Senior Vice President-Information Technology |
